Home » Newsletters » BioWorld Science

BioWorld Science

April 25, 2022

View Archived Issues

EGFR-TKI TAS-3351 overcomes T790M and C797S mutations tied to NSCLC treatment resistance

CLN-978, a next-generation CD19-targeted therapeutic for the treatment of B-cell malignancies

Chinese investigators patent new THR-beta agonists

CJRS-10671 and CJRS-10672, biotherapeutic candidates with promising antitumor efficacy in vivo

Gilead Sciences discloses new HIV antivirals

Yonsei University presents new SLC26A4 inhibitors

Chinese researchers identify new anti-claudin18.2 ADCs

New HIF-2alpha PET tracer presented by University of Texas System

PAX8-SOX17 tandem involved in tumor angiogenesis

PKMYT1 targeting useful for the treatment of CCNE1-amplified cancers

Sex disparities of lupus recapitulated in mouse model

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...
Janssen Pharmaceutica reports new TMEM175 activators
BioWorld Science
Janssen Pharmaceutica NV has identified new endosomal/lysosomal proton channel TMEM175 activators that are potentially useful for the treatment of Parkinson’s...